Cipla Q3 PAT dips 2.6 per cent at Rs 729 crore : Rashtra News #Cipla #PAT #dips #cent #crore The Mumbai-based company had posted a consolidated profit after tax (PAT) of Rs 748 crore in the October-December quarter of 2020-21 fiscal. Drug major Cipla on Tuesday reported a 2.6 per cent decline in its consolidated
Gains in Nifty Pharma were driven by industry major Cipla, which soared over 6 percent following its strong quarterly performance. The stock also happens to be the top gainer on the Nifty 50.
Cipla s Q3 revenue for the quarter grew 13.7% YoY to Rs 6,604 crore, compared to Rs 5,810 crore in the same quarter last year. However, the drugmaker saw a marginal decline from the previous quarter s revenue of Rs 6,678 crore. Meanwhile, its EBITDA surged 24.2% YoY to Rs 1,748 crore in the December quarter of FY24.